300 related articles for article (PubMed ID: 29467382)
21. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of cytochrome C oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death.
Wanka C; Brucker DP; Bähr O; Ronellenfitsch M; Weller M; Steinbach JP; Rieger J
Oncogene; 2012 Aug; 31(33):3764-76. PubMed ID: 22120717
[TBL] [Abstract][Full Text] [Related]
23. p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.
Nakamura H; Matoba S; Iwai-Kanai E; Kimata M; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Ariyoshi M; Mita Y; Ikeda K; Okigaki M; Adachi S; Tanaka H; Takamatsu T; Matsubara H
Circ Heart Fail; 2012 Jan; 5(1):106-15. PubMed ID: 22075967
[TBL] [Abstract][Full Text] [Related]
24. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress.
Kimata M; Matoba S; Iwai-Kanai E; Nakamura H; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Mita Y; Okigaki M; Ikeda K; Tatsumi T; Matsubara H
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1908-16. PubMed ID: 20935145
[TBL] [Abstract][Full Text] [Related]
25. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
[TBL] [Abstract][Full Text] [Related]
26. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway.
Schweikl H; Petzel C; Bolay C; Hiller KA; Buchalla W; Krifka S
Biomaterials; 2014 Mar; 35(9):2890-904. PubMed ID: 24411679
[TBL] [Abstract][Full Text] [Related]
27. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
28. Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis.
Yuan L; Tian C; Wang H; Song S; Li D; Xing G; Yin Y; He F; Zhang L
EMBO Rep; 2012 Apr; 13(4):363-70. PubMed ID: 22334068
[TBL] [Abstract][Full Text] [Related]
29. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia.
Hoshino A; Matoba S; Iwai-Kanai E; Nakamura H; Kimata M; Nakaoka M; Katamura M; Okawa Y; Ariyoshi M; Mita Y; Ikeda K; Ueyama T; Okigaki M; Matsubara H
J Mol Cell Cardiol; 2012 Jan; 52(1):175-84. PubMed ID: 22044588
[TBL] [Abstract][Full Text] [Related]
30. Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model.
Ajayi A; Yu X; Wahlo-Svedin C; Tsirigotaki G; Karlström V; Ström AL
Biochim Biophys Acta; 2015; 1847(4-5):418-428. PubMed ID: 25647692
[TBL] [Abstract][Full Text] [Related]
31. Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription.
Ha TK; Her NG; Lee MG; Ryu BK; Lee JH; Han J; Jeong SI; Kang MJ; Kim NH; Kim HJ; Chi SG
Cancer Res; 2012 Aug; 72(16):4097-109. PubMed ID: 22706202
[TBL] [Abstract][Full Text] [Related]
32. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
33. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
[TBL] [Abstract][Full Text] [Related]
34. Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl.
Mason EF; Zhao Y; Goraksha-Hicks P; Coloff JL; Gannon H; Jones SN; Rathmell JC
Cancer Res; 2010 Oct; 70(20):8066-76. PubMed ID: 20876800
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux.
Fu J; Yu S; Zhao X; Zhang C; Shen L; Liu Y; Yu H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555672
[TBL] [Abstract][Full Text] [Related]
36. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
[TBL] [Abstract][Full Text] [Related]
37. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
38. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
[TBL] [Abstract][Full Text] [Related]
39. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.
Kim J; Yu L; Chen W; Xu Y; Wu M; Todorova D; Tang Q; Feng B; Jiang L; He J; Chen G; Fu X; Xu Y
Cancer Cell; 2019 Feb; 35(2):191-203.e8. PubMed ID: 30712844
[TBL] [Abstract][Full Text] [Related]
40. Counteracting Colon Cancer by Inhibiting Mitochondrial Respiration and Glycolysis with a Selective PKCδ Activator.
Bessa C; Loureiro JB; Barros M; Isca VMS; Sardão VA; Oliveira PJ; Bernardino RL; Herman-de-Sousa C; Costa MA; Correia-de-Sá P; Alves MG; Rijo P; Saraiva L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]